Successful Surgical Intervention for the Management of Endocarditis due to Multidrug Resistant Candida parapsilosis: Case Report and Literature Review

Mycopathologia

Volumn 172, Issue 4, 2011, Pages 287-292

  Kumar, Jessica ^a   Fish, Douglas ^b   Burger, Harold ^c   Weiser, Barbara ^c   Ross, Jeffrey S ^d   Jones, David ^d   Robstad, Karl ^d   Li, Xiaojiang ^c   Chaturvedi, Vishnu ^e  

^a ALBANY MEDICAL COLLEGE   (United States)

^b AIDS Treatment Center and Department of Medicine   (United States)

^c WADSWORTH CENTER   (United States)

^d ALBANY MEDICAL CENTER   (United States)

^e Wadsworth Center of the New York State ^*  (United States)

Author keywords

Antifungal resistance; Candida parapsilosis; Endocarditis; HIV

Indexed keywords

ANTIFUNGAL AGENT;

CANDIDA; CANDIDIASIS; CASE REPORT; DRUG EFFECT; ENDOCARDITIS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PATHOLOGY; REVIEW; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, MULTIPLE, FUNGAL; ENDOCARDITIS; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); CANDIDA PARAPSILOSIS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 80052522266     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9430-x     Document Type: Review

References (28)

1. Garzoni C, Nobre V, Garbino J. Candida parapsilosis endocarditis: a comparative review of the literature. Eur J Clin Microbiol Infect Dis. 2007; 26(12): 915-26.
2. Fowler VGW Jr, Scheld M, Bayer AS. Cardiovascular Infections. In: Gerald L, Mandell JEB, Dolin Raphel, editors. Principles and Practices of Infectious Diseases. 5th ed. Maryland Heights, Missouri: Churchill Livingstone; 2000. p. 3263.
3. Marrie TJ, Cooper JH, Costerton JW. Ultrastructure of Candida parapsilosis endocarditis. Infect Immun. 1984; 45(2): 390-8.
4. Moudgal V, Little T, Boikov D, Vazquez JA. Multiechinocandin- and Multiazole-Resistant Candida parapsilosis Isolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis. Antimicrob Agents Chemother. 2005; 49(2): 767-9.
5. Martin E, Pancoast SJ, Neu HC. Candida parapsilosis Endocarditis: Medical and Surgical Cure. Ann Intern Med. 1979; 91(6): 870-1.
6. Girmenia C, Martino P, De Bernardis F, Gentile G, Boccanera M, Monaco M, Antonucci G, Cassone A. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis. 1996; 23(3): 506-14.
7. Nguyen MH, James EP, Arthur JM, David CT, Minh Ly N, David RS, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med. 1996; 100(6): 617-23.
8. Diekema DJ, Messer SA, Hollis RJ, Wenzel RP, Pfaller MA. An outbreak of Candida parapsilosis prosthetic valve endocarditis. Diagn Microbiol Infect Dis. 1997; 29(3): 147-53. doi: 10. 1016/S0732-8893(97)81804-4.
9. Pai MP, Samples ML, Mercier R-C, Spilde MN. Activities and Ultrastructural Effects of Antifungal Combinations against Simulated Candida Endocardial Vegetations. Antimicrob Agents Chemother. 2008; 52(7): 2367-76.
10. Zahid MA, Klotz SA, Hinthorn DR. Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis. Chest. 1994; 105(5): 1597-8.
11. Lejko-Zupanc T, Kozelj M. A case of recurrent Candida parapsilosis prosthetic valve endocarditis: Cure by medical treatment alone. J Infect. 1997; 35(1): 81-2. doi: 10. 1016/S0163-4453(97)91145-2.
12. López-Ciudad V, Castro-Orjales MJ, León C, Sanz-Rodríguez C, de la Torre-Fernández MJ, Pérez de Juan-Romero MA, Collell-Llach MD, Díaz-López MD. Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole. BMC Infect Dis. 2006; 6: 73.
13. Steinbach WJ, Perfect JR, Cabell CH, Fowler VG, Corey GR, Li JS, Zaas AK, Benjamin DK Jr. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005; 51(3): 230-47.
14. Samelson LE, Lerner SA, Resnekov L, Anagnostopoulos C. Relapse of Candida parapsilosis Endocarditis After Long-Term suppression with flucytosine: Retreatment with Valve Replacement and Ketoconazole. Ann Intern Med. 1980; 93(6): 838-9.
15. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008; 52(13): e1-142. doi: 10. 1016/j. jacc. 2008. 05. 007.
16. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE. Infectious diseases society of America. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004; 38(2): 161-89.
17. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009; 23(4): 525-30.
18. Rex John H, Walsh Thomas J, Sobel Jack D, Filler Scott G, Pappas Peter G, Dismukes William E, et al. Practice Guidelines for the Treatment of Candidiasis. Clin Infect Dis. 2000; 30(4): 662-78.
19. Mayrer AR, Brown A, Weintraub RA, Ragni M, Postic B. Successful medical therapy for endocarditis due to Candida parapsilosis A clinical and epidemiologic study. Chest. 1978; 73(4): 546-9.
20. San Miguel LG, Cobo J, Otheo E, Martos I, Muriel A, Fortún J, Moreno S. Candidemia in pediatric patients with congenital heart disease. Diagn Microbiol Infect Dis. 2006; 55(3): 203-7.
21. Gullu AU, Akcar M, Arnaz A, Kizilay M. Candida parapsilosis tricuspid native valve endocarditis: 3-year follow-up after surgical treatment. Interact CardioVasc Thorac Surg. 2008; 7(3): 513-4.
22. Malani AN, Aronoff DM. Voriconazole-Induced Photosensitivity. Clin Med Res. 2008; 6(2): 83-5.
23. Reyes MP, Ali A, Mendes RE, Biedenbach DJ. Resurgence of Pseudomonas Endocarditis in Detroit, 2006-2008. Medicine. 2009; 88(5): 294-301. doi: 10. 1097/MD. 0b013e3181b8bedc.
24. Khan MU, Ali S, Baig MA, Rafiq MA, Vasavada BC, Khan IA. Candida parapsilosis endocarditis 8 months after transient candidemia. Int J Cardiol. 2007; 118(2): e58-9.
25. Marti J. Candida parapsilosis endocarditis in aged patient. Eur J Intern Med. 2009; 20(1): e15.
26. Daas H, Abuhmaid F, Zervos M. Successful treatment of Candida parapsilosis and Pseudomonas aeruginosa infection using medical and surgical management in an injecting drug user with mitral and aortic valve endocarditis: a case report. J Med Case Rep. 2009; 3: 6598.
27. Rodriguez D, Almirante B, Park BJ, Cuenca-Estrella M, Planes AM, Sanchez F, Gene A, Xercavins M, Fontanals D, Rodriguez-Tudela JL, Warnock DW, Pahissa A. Barcelona Candidemia project study group. Candidemia in neonatal intensive care units: Barcelona, Spain. Pediatr Infect Dis J. 2006; 25(3): 224-9.
28. Talarmin JP, Boutoille D, Tattevin P, Abgueguen P, Ansart S, Roblot F, et al. Candida endocarditis: role of new antifungal agents. Mycoses. 2009; 52(1): 60-6.